Patents by Inventor Gregory Pogue

Gregory Pogue has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20080084014
    Abstract: The invention is directed toward a retrofit jig system for use with an existing truss assembly table having multiple planks extending lengthwise along the table. The jig system includes a motor and jig assembly for moving a puck lengthwise along the truss assembly table between adjacent planks of the table. A support member supports the screw between the adjacent planks. The support member is adjustable to allow the puck to move past the support member without interference.
    Type: Application
    Filed: September 28, 2007
    Publication date: April 10, 2008
    Applicant: MITEK HOLDINGS, INC.
    Inventors: Kieth Godwin, Gerald McCoombe, Gregory Pogue, Ferdie Tenshler, Jack Dodd, Adam McClenahan
  • Publication number: 20060218667
    Abstract: The present invention relates to plant produced native aprotinin and aprotinin variants having enzyme-inhibitory, immunological and pharmacokinetic properties and their preparation. In a preferred method a recombinant RNA plant virus is used to express native aprotinin+variants thereof in Nicotiana plants.
    Type: Application
    Filed: October 12, 2005
    Publication date: September 28, 2006
    Inventors: Fakhrieh Vojdani, Kenneth Palmer, Stephen Garger, Gregory Pogue
  • Publication number: 20060188991
    Abstract: Herein-described are various methods for making a vaccine that are made of re-assembled virus like particles (VLP). First, the VLPs are disassembled into encapsidation intermediate populations. Each encapsidation intermediate population undergoes, for instance, chemical conjugation of unique peptide or nucleic moieties to form separate populations. Thereafter, a predetermined amount of each of the several (one or more) different encapsidation intermediates from the different populations is mixed and joined, forming intact VLPs, surrounding a nucleic acid core, that are composed of different encapsidation intermediate such that the reassembled VLP displays more than one peptide or nucleic acid. The nucleic acid can function either as a scaffold alone or can be engineered for the expression of an immunomodulatory protein in a eukaryotic cell.
    Type: Application
    Filed: April 24, 2006
    Publication date: August 24, 2006
    Inventors: Alison McCormick, Mark Smith, Kenneth Palmer, John Lindbo, Long Nguyen, Gregory Pogue
  • Publication number: 20060159696
    Abstract: The invention provides a fusion protein comprising a plant virus coat protein and a GDF8 peptide domain, or antigenic fragment of the GDF8 peptide domain. Plant virus vectors expressing the fusion protein and methods of using these vectors are also provided.
    Type: Application
    Filed: December 21, 2005
    Publication date: July 20, 2006
    Inventors: David Junker, Mark Cochran, Mark Smith, Kenneth Palmer, Gregory Pogue
  • Publication number: 20060134604
    Abstract: A plurality of proteins of interest, or peptides of interest, or other genetically expressed materials, are screened and subsequently produced using any of a variety of expression systems. The plurality of proteins are extracted from a plurality of separate, processed green juices, each green juice containing one of the proteins of interest. A multi-channel apparatus processes the various green juices, one green juice per channel. The apparatus is computer controlled such that the various valves in each channel and pump are controlled in an automated manner to extract each protein of interest and deliver each protein of interest into its own storage vessel.
    Type: Application
    Filed: December 16, 2005
    Publication date: June 22, 2006
    Inventors: Mark Smith, Kenneth Palmer, Gregory Pogue, John Lindbo, Kathleen Hanley, David Mannion, Gershon Wolfe
  • Publication number: 20060029612
    Abstract: Juvenile-onset recurrent respiratory papillomatosis is treated using active vaccination or passive immune therapy of neutralizing antibodies against HPV L2 neutralizing epitopes.
    Type: Application
    Filed: April 15, 2005
    Publication date: February 9, 2006
    Applicant: LARGE SCALE BIOLOGY CORPORATION
    Inventors: Kenneth Palmer, Daniel Tuse, Stephen Reinl, Mark Smith, Gregory Pogue
  • Publication number: 20060024272
    Abstract: The invention described herein provides a C-terminally truncated interferon having enhanced biological activity and the polynucleotides encoding such interferon. Also provided are methods for producing and using such truncated interferon.
    Type: Application
    Filed: June 29, 2005
    Publication date: February 2, 2006
    Inventors: Stephen Reinl, Gregory Pogue
  • Publication number: 20060024821
    Abstract: A rolling circle DNA replicon which replicates in a host eukaryotic cell is disclosed which has a truncated replication cycle. The rolling circle DNA replicon comprises the following elements present on the same DNA molecule. It contains a Rep gene open reading frame from a virus belonging to the viral taxonomic families Geminiviridae, Circoviridae or genus Nanovirus. The Rep gene open reading frame is placed under transcriptional control of a promoter, which is placed 5? of the gene. Any sequences that are required to be present in cis on the rolling circle DNA replicon in order that the Rep protein might promote replication of the rolling circle DNA replicon are included. An expression cassette for expression of an ancillary protein that is capable of creating a cellular environment permissive for replication of the rolling circle DNA replicon in the host cell of interest is also included.
    Type: Application
    Filed: September 20, 2005
    Publication date: February 2, 2006
    Applicant: Large Scale Biology Corporation
    Inventors: Kenneth Palmer, Gregory Pogue
  • Publication number: 20050282263
    Abstract: Herein described are various methods for making a vaccine that are made of re-assembled virus like particles (VLP). First, the VLPs are disassembled into coat proteins or encapsidation intermediate populations. Each population undergoes, for instance, chemical conjugation of unique peptide or nucleic moieties to form separate populations. Thereafter, a predetermined amount of each of the several (one or more) different coat proteins or encapsidation intermediates from the different populations is mixed and joined, forming intact VLPs, surrounding a nucleic acid core, that are composed of different coat proteins such that the reassembled VLP displays more than one peptide or other molecule. The nucleic acid can function either as a scaffold alone or can be engineered for the expression of an immunomodulatory protein in a eukaryotic cell.
    Type: Application
    Filed: March 25, 2005
    Publication date: December 22, 2005
    Applicant: LARGE SCALE BIOLOGY CORPORATION
    Inventors: Alison McCormick, Mark Smith, Kenneth Palmer, John Lindbo, Long Nguyen, Gregory Pogue
  • Publication number: 20050175590
    Abstract: The present invention provides nucleic acid sequences having an altered viral movement protein and 126/183 kDa replicase proteins further characterized in its ability tostabilize a transgene contained in a virus that expresses the altered movement protein. The present invention also provides viral vectors expressing the altered movement protein, cells transformed with the vectors, and host plants infected by the viral vectors.
    Type: Application
    Filed: July 21, 2003
    Publication date: August 11, 2005
    Applicant: Large Scale Biology Corporation
    Inventors: Wayne Fitzmaurice, Gregory Pogue, John Lindbo
  • Publication number: 20050009012
    Abstract: The present invention relates to recombinant viral vectors encoding a transcriptional unit, that encodes a fusion protein, or a foreign protein or a gene of interest to be silenced, which can be expressed in a host. The present invention also relates to the use of these recombinant viral vectors to express a fusion protein, a foreign protein, to silence a gene of interest in a host. The present invention also relates to the use of these recombinant viral vectors to screen a cDNA or genomic library in order to correlate a nucleotide sequence with a phenotypic or biochemical change.
    Type: Application
    Filed: August 6, 2004
    Publication date: January 13, 2005
    Inventors: Steven Holzberg, Gregory Pogue
  • Publication number: 20050005319
    Abstract: The present invention provides methods for rapidly determining the function of nucleic acid sequences by transfecting the same into a host organism to effect expression. Phenotypic and biochemical changes produced thereby are then analyzed to ascertain the function of the nucleic acids which have been transfected into the host organism. The invention also provides methods for silencing endogenous genes by transfecting hosts with nucleic acid sequences to effect expression of the same. The present invention also provides methods for selecting desired functions of RNAs and proteins by the use of virus vectors to express libraries of nucleic acid sequence variants. Moreover, the present invention provides methods for inhibiting an endogenous protease of a plant host.
    Type: Application
    Filed: July 16, 2004
    Publication date: January 6, 2005
    Applicant: LARGE SCALE BIOLOGY CORPORATION
    Inventors: Guy della-Cioppa, Robert Erwin, Wayne Fitzmaurice, Kathleen Hanley, Moaro Kumagai, John Lindbo, David McGee, Hal Padgett, Gregory Pogue